Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Vamsi Parimi"'
Autor:
Vamsi Parimi, Khaled Tolba, Natalie Danziger, Zheng Kuang, Daokun Sun, Douglas I. Lin, Matthew C. Hiemenz, Alexa B. Schrock, Jeffrey S. Ross, Geoffrey R. Oxnard, Richard S. P. Huang
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-8 (2023)
Abstract In this study, we report the clinicopathologic and genomic profiles of 891 patients with RET fusion driven advanced solid tumors. All patient samples were tested using a tissue-based DNA hybrid capture next generation sequencing (NGS) assay
Externí odkaz:
https://doaj.org/article/91c1ba901dc249f3ae1af6da4be2810e
Autor:
Ann E. Elsner, Brittany R. Walker, Robert N. Gilbert, Vamsi Parimi, Joel A. Papay, Thomas J. Gast, Stephen A. Burns
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
PurposeCones in diabetic patients are at risk due to metabolic and vascular changes. By imaging retinal vessel modeling at high magnification, we reduced its impact on cone distribution measurements. The retinal vessel images and retinal thickness me
Externí odkaz:
https://doaj.org/article/cebb9f6446714422833b17a20caa7a12
Autor:
Abbas Hadji, Paolo Ceppi, Andrea E. Murmann, Sonia Brockway, Abhinandan Pattanayak, Bhavneet Bhinder, Annika Hau, Shirley De Chant, Vamsi Parimi, Piotre Kolesza, JoAnne Richards, Navdeep Chandel, Hakim Djaballah, Marcus E. Peter
Publikováno v:
Cell Reports, Vol 7, Iss 1, Pp 208-222 (2014)
CD95 (Fas/APO-1), when bound by its cognate ligand CD95L, induces cells to die by apoptosis. We now show that elimination of CD95 or CD95L results in a form of cell death that is independent of caspase-8, RIPK1/MLKL, and p53, is not inhibited by Bcl-
Externí odkaz:
https://doaj.org/article/259dd43c9ca746b4af0d5d9ec8e14da5
Autor:
Tamer Refaat, Derek West, Samar El Achy, Vamsi Parimi, Jasmine May, Lun Xin, Kathleen R. Harris, William Liu, Michael Beau Wanzer, Lydia Finney, Evan Maxey, Stefan Vogt, Reed A. Omary, Daniele Procissi, Andrew C. Larson, Tatjana Paunesku, Gayle E. Woloschak
Publikováno v:
Nanomaterials, Vol 6, Iss 8, p 143 (2016)
This work compares intravenous (IV) versus fluoroscopy-guided transarterial intra-catheter (IC) delivery of iron oxide core-titanium dioxide shell nanoparticles (NPs) in vivo in VX2 model of liver cancer in rabbits. NPs coated with glucose and decora
Externí odkaz:
https://doaj.org/article/51233af3789a42ac85d03ac745eb3bbc
Autor:
Natalie Danziger, Ethan S Sokol, Ryon P Graf, Matthew C Hiemenz, Jake Maule, Vamsi Parimi, Carlo Palmieri, Lajos Pusztai, Jeffrey S Ross, Richard S P Huang
Publikováno v:
The Oncologist. 28:319-326
Background In 2020, pembrolizumab was approved as a therapy for triple-negative breast cancer (TNBC) with the companion diagnostic DAKO 22C3 programmed death ligand-1 (PD-L1) immunohistochemistry assay. The study aimed to determine the landscape of P
Autor:
Vamsi Parimi, Woonyoung Choi, Mingxiao Feng, Megan Fong, Jean Hoffman‐Censits, Max Kates, Kara A. Lombardo, Eva Comperat, David J. McConkey, Noah M. Hahn, Rodrigo Salgado Esteves, Andres Matoso
Publikováno v:
Histopathology. 82:991-1002
Autor:
Vamsi Parimi, Woonyoung Choi, Mingxiao Feng, Megan Fong, Jean Hoffman‐Censits, Max Kates, Kara A. Lombardo, Eva Comperat, David J. McConkey, Noah M. Hahn, Rodrigo Salgado Esteves, Andres Matoso
Publikováno v:
Histopathology. 82
Autor:
Kyle Rose, Andrea Necchi, Facundo Davaro, Elizabeth Davaro, Heather Huelster, Joseph Jacob, Grennady Bratslavsky, Dean Pavlick, Douglas Lin, Natalie Danzinger, Petros Grivas, Hikmat Al-Ahmadie, Vamsi Parimi, Philippe Spiess, Bishoy Faltas, Jeffrey Ross, Roger Li
Publikováno v:
Journal of Urology. 209
Autor:
Thomas V. O'Halloran, Vincent L. Cryns, Vamsi Parimi, Elden P. Swindell, Meera R. Raja, Anil K. Patri, Jeffrey D. Clogston, Stephan T. Stern, Haimei Chen, Feng Chen, Richard W. Ahn
Supplementary Data from A Novel Nanoparticulate Formulation of Arsenic Trioxide with Enhanced Therapeutic Efficacy in a Murine Model of Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4450b1fd859cb0b60dfcf9cb1811821b
https://doi.org/10.1158/1078-0432.22442936
https://doi.org/10.1158/1078-0432.22442936
Autor:
Thomas V. O'Halloran, Vincent L. Cryns, Vamsi Parimi, Elden P. Swindell, Meera R. Raja, Anil K. Patri, Jeffrey D. Clogston, Stephan T. Stern, Haimei Chen, Feng Chen, Richard W. Ahn
Purpose: The clinical success of arsenic trioxide (As2O3) in hematologic malignancies has not been replicated in solid tumors due to poor pharmacokinetics and dose-limiting toxicity. We have developed a novel nanoparticulate formulation of As2O3 enca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97ff2b9bd930deb0bb614fcd828ebe35
https://doi.org/10.1158/1078-0432.c.6519557.v1
https://doi.org/10.1158/1078-0432.c.6519557.v1